Absci to participate in the ubs genomics 2.0 and medtech innovations summit conference

Vancouver, wash. and new york, aug. 01, 2022 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning ai and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating in the upcoming ubs genomics 2.0 and medtech innovations summit conference in dana point, ca.
ABSI Ratings Summary
ABSI Quant Ranking